Brochure | September 21, 2020

Solutions For Monoclonal Antibody Manufacturing

Source: Avantor

Each stage of bioprocessing is influences by the steps preceding it. In the production of monoclonal antibodies (mAbs), manufacturing challenges such as reducing visibility, increasing yields, effective separation of impurities in downstream purification or achieving high protein concentration in formulation and drug product stability must be effectively managed in order to successfully complete regulatory review processes and bring new, life-altering medicines to the market.

As a trusted supplier for the top 20 biopharmaceutical companies, Avantor's expertise and solutions address the complexity of mAbs manufacturing. From process development and scale-up, through commercial manufacturing, we offer the products and support you need to help maintain mAbs quality, activity and stability throughout the entire process.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: